The reduction of T2R-mediated NO generation upon loss of CFTR function may explain discrepancies and/or subtle effects of TAS2R38 genetics (PAV vs AVI alleles) on CF disease progression. The gene discussed is TAS2R38; the disease is cystic fibrosis.